Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imbruvica
Imbruvica
FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications
Marketwatch
Mon, 07/28/14 - 01:28 pm
FDA
Imbruvica
chronic lymphocytic leukemia
Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land
Fierce Pharma Marketing
Thu, 06/26/14 - 10:21 am
drug launches
Tecfidera
Sovaldi
Aubagio
Imbruvica
Tivicay
Breo Ellipta and Anoro Ellipta
Kadcyla
Invokana
Pomolyst
Pharmacyclics reports sNDA for Imbruvica accepted, priority review granted
The Fly on the Wall
Mon, 06/9/14 - 09:45 am
Pharmacyclics
Imbruvica
ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
Yahoo/Benzinga
Wed, 06/4/14 - 03:20 pm
ASCO
cancer
Imbruvica
JNJ
Eli Lilly
Cyramza
Pharmacyclics' Imbruvica Extends Survival in Elderly Leukemia Patients
The Street
Sat, 05/31/14 - 10:32 am
Pharmacyclics
Imbruvica
leukemia
3 Breakthrough Drugs Yield 1 Instant Blockbuster
Motley Fool
Sun, 05/25/14 - 10:26 am
Roche
Gazyva
Imbruvica
JNJ
Gilead Sciences
Sovaldi
mantle cell lymphoma
chronic lymphocytic leukemia
leukemia
Biogen
hepatitis
hepatitus C
1 Biotech Refusing to Stick Its Neck Out
Motley Fool
Mon, 05/19/14 - 09:34 am
Pharmacyclics
Imbruvica
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thu, 05/15/14 - 08:29 am
ASCO
Gilead Sciences
AbbVie
Pharmacyclics
Imbruvica
CLL
Idelalisib
mantle cell lymphoma
ABT-199
Say Hello to 3 Existing and Upcoming Next-Generation Blockbuster Drugs
Motley Fool
Sun, 04/27/14 - 09:51 am
Sovaldi
Gilead Sciences
Imbruvica
Pharmacyclics
JNJ
Eliquis
Bristol-Myers Squibb
Pfizer
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data
Yahoo/Zacks.com
Wed, 04/16/14 - 10:22 am
MannKind
Alkermes
Gilead Sciences
ledipasvir
AbbVie
Afrezza
aripiprazole lauroxil
Pharmacyclics
Imbruvica
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura
Investors.com
Thu, 03/20/14 - 05:26 pm
Imbruvica
Pharmacyclics
Gilead Sciences
Biogen Idec
chronic lymphocytic leukemia
J&J, Pharmacyclics drug gets U.S. approval for leukemia
Yahoo/Reuters
Wed, 02/12/14 - 06:46 pm
FDA
JNJ
Pharmacyclics
Imbruvica
chronic lymphocytic leukemia
Valeant Dreams Big; Cancer Drug News Lifts Pharmacyclics
Yahoo/Investors Business Daily
Wed, 01/8/14 - 08:05 am
Valeant Pharmaceuticals
Pharmacyclics
Imbruvica
Celgene
EPZ-5676
Epizyme
Pharmacyclics Shares Rise on Positive Leukemia Trial
Bloomberg
Tue, 01/7/14 - 11:49 am
Pharmacyclics
JNJ
Imbruvica
chronic lymphocytic leukemia
Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
Seeking Alpha
Fri, 01/3/14 - 11:56 am
Pharmacyclics
Imbruvica
JNJ
Roche
Celgene
Gilead Sciences
mantle cell lymphoma
Celgene and Pharmacyclics Bring Big Change to Mantle Cell Lymphoma in 2013
Motley Fool
Sat, 12/14/13 - 12:03 pm
Celgene Corporation
Pharmacyclics
mantle cell lymphoma
JNJ
Imbruvica
Revlimid
J&J, Roche, Novartis tout key cancer-drug data at ASH
Fierce Pharma
Mon, 12/9/13 - 10:12 am
JNJ
Roche
Novartis
Imbruvica
Tasigna
CLL
Gazyva
Four Biotech 'Surprise' Stocks for 2014
TheStreet.com
Wed, 11/27/13 - 08:34 am
Seattle Genetics
Adcetris
Cubist Pharmaceuticals
Cempra
Eylea
Regeneron
Pharmacyclics
Imbruvica
Gilead
sofosbuvir
Johnson & Johnson’s Imbruvica Will Be a Costly Treatment
Wall St Cheat Sheet
Mon, 11/18/13 - 04:36 pm
JNJ
Imbruvica
mantle cell lymphoma
Pharmacyclics
Why Aren't Investors More Excited About Pharmacyclics' FDA Approval?
Motley Fool
Sat, 11/16/13 - 01:15 pm
Pharmacyclics
Imbruvica
mantle cell lymphoma
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »